Target intelligence / Profile preview

DEAH box polypeptide 29 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

DEAH-box polypeptide 29 pseudogene" (ENSG00000230987, LOC647132) refers to a *pseudogene*, which is a non-functional copy of a protein-coding gene—in this case, of the **DEAH-box helicase 29 (DHX29)** gene. Pseudogenes do not encode functional proteins, and by definition, lack the molecular function and druggability inherent to bona fide therapeutic targets[3]. The functional DHX29 gene product is an RNA helicase involved in translation initiation and possibly cancer cell proliferation, but the pseudogene neither encodes this protein nor assumes those biological roles[1][3]. Pseudogenes, while potentially involved in gene regulation or as disease biomarkers, are generally not considered therapeutic targets unless there is clear evidence to the contrary, which is lacking in this case[3][5]. Notes: - The term "pseudogene" indicates that ENSG00000230987 is distinguished from the functional DHX29 gene (ENSG00000067248), and does not itself encode a functional helicase or any protein[3]. - There is nothing to suggest this pseudogene is a therapeutic target, nor are there drugs or mechanisms of action relevant to it. - If the goal is to target the *functional* helicase (DHX29), information should reference the protein-coding gene, not its pseudogene[1]. Critical clarification: This target is a *pseudogene*, not a receptor, enzyme, transporter, or any canonical therapeutic target[3]. It is not actionable in the conventional sense used in drug discovery or biomedical therapeutics.

Other names
DEAH box polypeptide 29 pseudogeneLOC647132ENSG00000230987
02

Biological functions

Other (non-functional, does not participate directly in biological processes)
03

Disease associations

Other (pseudogenes may have indirect roles as biomarkers, but no established disease association for this specific pseudogene)

Beyond the preview

Go deeper on DEAH box polypeptide 29 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAH box polypeptide 29 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call